FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4319057669> ?p ?o ?g. }

• W4319057669 endingPage "457" @default.
• W4319057669 startingPage "449" @default.
• W4319057669 abstract "Virtual reality-delivered psychological therapies have recently been investigated as non-pharmacological management for acute and chronic pain. However, no virtual reality pain therapy software existed that met the needs of cancer patients with neuropathic pain. We created a bespoke virtual reality-delivered pain therapy software programme to help cancer patients manage neuropathic pain incorporating guided visualisation and progressive muscle relaxation techniques, whilst minimising the risk of cybersickness in this vulnerable patient population. This randomised controlled pilot study evaluated the feasibility, acceptability, recruitment rates and risk of cybersickness of this pain therapy software programme. Clinical outcomes including opioid consumption, pain severity, pain interference and global quality of life scores were secondary aims. Of 87 eligible cancer patients with neuropathic pain, 39 were recruited (47%), allocated to either the intervention (20 patients, virtual reality pain therapy software programme) or control (19 patients, viewing virtual reality videos). Four patients withdrew before the 3-month follow-up (all in the control group). Pre-existing dizziness (Spearman ρ 0.37, p = 0.02) and pre-existing nausea (Spearman ρ 0.81, p < 0.001) were significantly associated with risk of cybersickness in both groups. Patients in the intervention group reported less cybersickness, as well as tolerated and completed all therapy sessions. At 1- and 3-month follow-up, there were trends in the intervention group towards reductions in: oral morphine equivalent daily dose opioid consumption (-8 mg and -4 mg; vs. control: 0 mg and +15 mg respectively); modified Brief Pain Inventory pain severity (-0.4, -0.8; vs. control +0.4, -0.3); and pain interference (-0.9, -1.8; vs. control -0.2, -0.3) scores. The global quality of life subscale from the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-C30 was not significantly changed between groups at 1 and 3 months (intervention: -5, -8; vs. control: +3, +4). This newly created virtual reality-delivered pain therapy software programme was shown to be feasible and acceptable to cancer patients with neuropathic pain. These results will aid the design of a definitive multicentre randomised controlled trial." @default.
• W4319057669 created "2023-02-04" @default.
• W4319057669 creator A5005804042 @default.
• W4319057669 creator A5025217582 @default.
• W4319057669 creator A5025495100 @default.
• W4319057669 creator A5031119545 @default.
• W4319057669 creator A5037078466 @default.
• W4319057669 creator A5045203956 @default.
• W4319057669 creator A5062468644 @default.
• W4319057669 creator A5071226647 @default.
• W4319057669 creator A5086921564 @default.
• W4319057669 date "2023-02-02" @default.
• W4319057669 modified "2023-09-27" @default.
• W4319057669 title "Feasibility of virtual reality‐delivered pain psychology therapy for cancer‐related neuropathic pain: a pilot randomised controlled trial" @default.
• W4319057669 cites W1555005593 @default.
• W4319057669 cites W2024830167 @default.
• W4319057669 cites W2031386946 @default.
• W4319057669 cites W2034120147 @default.
• W4319057669 cites W2073051214 @default.
• W4319057669 cites W2084514147 @default.
• W4319057669 cites W2086042012 @default.
• W4319057669 cites W2167571044 @default.
• W4319057669 cites W2463089356 @default.
• W4319057669 cites W2763999049 @default.
• W4319057669 cites W2892344530 @default.
• W4319057669 cites W2908455676 @default.
• W4319057669 cites W2912064434 @default.
• W4319057669 cites W2982008407 @default.
• W4319057669 cites W3046204860 @default.
• W4319057669 cites W3069151061 @default.
• W4319057669 cites W3092607654 @default.
• W4319057669 cites W3092667344 @default.
• W4319057669 cites W4225758319 @default.
• W4319057669 doi "https://doi.org/10.1111/anae.15971" @default.
• W4319057669 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36734021" @default.
• W4319057669 hasPublicationYear "2023" @default.
• W4319057669 type Work @default.
• W4319057669 citedByCount "0" @default.
• W4319057669 crossrefType "journal-article" @default.
• W4319057669 hasAuthorship W4319057669A5005804042 @default.
• W4319057669 hasAuthorship W4319057669A5025217582 @default.
• W4319057669 hasAuthorship W4319057669A5025495100 @default.
• W4319057669 hasAuthorship W4319057669A5031119545 @default.
• W4319057669 hasAuthorship W4319057669A5037078466 @default.
• W4319057669 hasAuthorship W4319057669A5045203956 @default.
• W4319057669 hasAuthorship W4319057669A5062468644 @default.
• W4319057669 hasAuthorship W4319057669A5071226647 @default.
• W4319057669 hasAuthorship W4319057669A5086921564 @default.
• W4319057669 hasBestOaLocation W43190576691 @default.
• W4319057669 hasConcept C121608353 @default.
• W4319057669 hasConcept C126322002 @default.
• W4319057669 hasConcept C141071460 @default.
• W4319057669 hasConcept C154945302 @default.
• W4319057669 hasConcept C159110408 @default.
• W4319057669 hasConcept C168563851 @default.
• W4319057669 hasConcept C1862650 @default.
• W4319057669 hasConcept C194969405 @default.
• W4319057669 hasConcept C2777107010 @default.
• W4319057669 hasConcept C2778904085 @default.
• W4319057669 hasConcept C2779951463 @default.
• W4319057669 hasConcept C2780052408 @default.
• W4319057669 hasConcept C2780580376 @default.
• W4319057669 hasConcept C2781118164 @default.
• W4319057669 hasConcept C2908647359 @default.
• W4319057669 hasConcept C41008148 @default.
• W4319057669 hasConcept C42219234 @default.
• W4319057669 hasConcept C71924100 @default.
• W4319057669 hasConcept C99454951 @default.
• W4319057669 hasConceptScore W4319057669C121608353 @default.
• W4319057669 hasConceptScore W4319057669C126322002 @default.
• W4319057669 hasConceptScore W4319057669C141071460 @default.
• W4319057669 hasConceptScore W4319057669C154945302 @default.
• W4319057669 hasConceptScore W4319057669C159110408 @default.
• W4319057669 hasConceptScore W4319057669C168563851 @default.
• W4319057669 hasConceptScore W4319057669C1862650 @default.
• W4319057669 hasConceptScore W4319057669C194969405 @default.
• W4319057669 hasConceptScore W4319057669C2777107010 @default.
• W4319057669 hasConceptScore W4319057669C2778904085 @default.
• W4319057669 hasConceptScore W4319057669C2779951463 @default.
• W4319057669 hasConceptScore W4319057669C2780052408 @default.
• W4319057669 hasConceptScore W4319057669C2780580376 @default.
• W4319057669 hasConceptScore W4319057669C2781118164 @default.
• W4319057669 hasConceptScore W4319057669C2908647359 @default.
• W4319057669 hasConceptScore W4319057669C41008148 @default.
• W4319057669 hasConceptScore W4319057669C42219234 @default.
• W4319057669 hasConceptScore W4319057669C71924100 @default.
• W4319057669 hasConceptScore W4319057669C99454951 @default.
• W4319057669 hasIssue "4" @default.
• W4319057669 hasLocation W43190576691 @default.
• W4319057669 hasLocation W43190576692 @default.
• W4319057669 hasOpenAccess W4319057669 @default.
• W4319057669 hasPrimaryLocation W43190576691 @default.
• W4319057669 hasRelatedWork W107835582 @default.
• W4319057669 hasRelatedWork W2073423035 @default.
• W4319057669 hasRelatedWork W2089933404 @default.
• W4319057669 hasRelatedWork W2164677243 @default.
• W4319057669 hasRelatedWork W2214143905 @default.
• W4319057669 hasRelatedWork W2371979460 @default.

• next